SCHEMBL31695366

SCHEMBL31695366

N#Cc1c(-c2ccc(O)cc2)cc(-c2ccc(F)cc2)[nH]c1=O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 6/20 0.67
ATM Q13315 1/20 0.63
KMT2A Q03164 3/20 0.60
KDM4E B2RXH2 2/20 0.60
GAA P10253 2/20 0.60
MAPT P10636 2/20 0.60
ALDH1A1 P00352 1/20 0.60
HTT P42858 1/20 0.60
BIRC5 O15392 2/20 0.56
MET P08581 8/20 0.55
KDR P35968 8/20 0.55
GSK3B P49841 1/20 0.51
MEN1 O00255 2/20 0.48
USP2 O75604 1/20 0.48
GLA P06280 1/20 0.48
POLB P06746 1/20 0.48
APEX1 P27695 1/20 0.48
RECQL P46063 1/20 0.48
BLM P54132 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23841105 0.88 ATM (0.83) PIM1ATMKMT2AKDM4EGAA
SCHEMBL31695353 0.87 ATM (0.61) PIM1ATMKMT2AKDM4EGAA
SCHEMBL23841104 0.87 KMT2A (0.57) PIM1ATMKMT2AKDM4EGAA
SCHEMBL31695363 0.82 MET (0.64) PIM1ATMKMT2AKDM4EGAA
SCHEMBL31695310 0.81 KMT2A (0.63) PIM1ATMKMT2AKDM4EGAA
SCHEMBL23841103 0.81 MET (0.67) PIM1ATMKMT2AKDM4EGAA
SCHEMBL23841110 0.77 KDM4E (0.59) PIM1ATMKMT2AKDM4EGAA
SCHEMBL14944227 0.77 KDM4E (0.78) PIM1ATMKMT2AKDM4EGAA
SCHEMBL25377987 0.75 KDM4E (0.53) PIM1ATMKMT2AKDM4EGAA
SCHEMBL3838859 0.75 ATM (0.67) PIM1ATMKMT2AKDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250313530-A1 SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4 AND USES THEREOF TRUSTEES OF BOSTON UNIVERSITY (US) 2025-10-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250313530-A1 SMALL MOLECULE INHIBITORS OF INTERLEUKIN-4 AND USES THEREOF IL4, IRAK4, IL5 PIM1 585/4885ATM 1125/4885KMT2A 2417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.